Sequentify has partnered with Dexter to provide Romania with Sequentify's InfiniSeq library preparation solutions used for next-generation sequencing (NGS).
This partnership provides an affordable alternative for NGS by introducing Sequentify's technology that simplifies and hastens sample preparation for sequencing. Dexter aims to further distribute Sequentify's range of genomic solutions throughout Romania, enhancing access to genomics diagnostic tools such as the InfiniSeq Expanded BRCA Panel, which is for tracking cancer progression and assessing hereditary cancer risks.
Sequentify, founded as a spinoff from the Weizmann Institute of Science in Rehovot, Israel, specializes in DNA sequencing technology. The company's core offering, its InfiniSeq technology, enables rapid targeted DNA sequencing by combining synthetic biology and AI software tools and is adaptable to most sequencing instruments. Sequentify's product portfolio also includes NGS libraries and software for applications such as cancer diagnostics, carrier screening, and Covid-19 surveillance.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.